Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia

SIMPLE SUMMARY: Outcomes for patients with chronic lymphocytic leukemia (CLL) have significantly improved over the past decade with the introduction of targeted therapies. These medications have improved survival, with good tolerability. However, for patients in need of treatment who are refractory...

Descripción completa

Detalles Bibliográficos
Autores principales: Heyman, Benjamin M., Tzachanis, Dimitrios, Kipps, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996890/
https://www.ncbi.nlm.nih.gov/pubmed/35406490
http://dx.doi.org/10.3390/cancers14071715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996890/
https://www.ncbi.nlm.nih.gov/pubmed/35406490
http://dx.doi.org/10.3390/cancers14071715

Ejemplares similares